efficacy of semaglutide

efficacy of semaglutide and safety once-weekly monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial sustain 6 trial A1C & Weight Results |

Name: efficacy of semaglutide and safety once-weekly monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial sustain 6 trial A1C & Weight Results |
Brand: stastnyfoto.com
SKU: 82067863249
Price: 25.30 USD
Availability: InStock
Rating: 4.610200000000001 (12 reviews)

SKU: 82067863249

4.6

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 3 - Sep 8

Description

Then, wash your hands thoroughly with soap and remove the pen cap

Participants in the trial who used tirzepatide had better improved A1C, lost more weight, and had less instances of hypoglycemia than those who used fast-acting insulin.

The therapy lasted for 2 weeks

Generally, tirzepatide seems to have an edge over semaglutide, with people losing up to 22.5% of their weight, compared to an average of 17% with semaglutide